Curie.Bio

About Curie.Bio

Curie.Bio is a venture capital firm focused on helping founders discover and develop important new medicines. They support drug discovery and development from concept to clinical stages, providing both capital and expertise.

Products & Services

Investment Services:Curie.Bio invests in companies at various stages, from concept to clinical trials, through their Seed Fund ($5-15M for preclinical milestones) and Breakout Fund (for clinical trials to generate impactful data).

Drug Development Support:Beyond funding, Curie.Bio offers operational and scientific support with a team of over 100 experienced drug discovery scientists and operators, helping founders elevate ideas, create R&D plans, develop drugs, and raise additional capital.

Core Services:End-to-end operational support including talent recruitment, capital raising, and back-office management to allow founders to focus on science.

Specialties

Drug Discovery Drug Development Clinical Trials Preclinical Milestones Therapy Advancement

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 380000000 MR: - FA: $380 million FAN: 380000000	D: 2024-06-26 FD: 2024-06-26	-

Series A Latest

2024-06-26

$380.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

Z

Zach Weinberg

CEO

A

Alexis Borisy

Operating Chairman

C

Christoph Lengauer

CSO

T

Tom Hotchkiss

Chief Infrastructure Officer

B

Ben Auspitz

Managing Partner, Breakout Fund

C

Chris De Savi

CSO Partner

View 99 more team members with Pro

Unlock Full Team Directory

Recent News

Curie.Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised